Canine Heartworm Disease and Flea Prevention: Integrated Parasite Control
Etiology and Parasite Biology
Canine heartworm disease is caused by the filarial nematode Dirofilaria immitis, a mosquito-borne parasite that resides in the pulmonary arteries and right ventricle of infected canids [1, 2]. The adult worms are long, slender, and white, with females reaching lengths of 25 to 30 cm and males measuring 12 to 16 cm [3]. The parasite requires an intermediate host, mosquitoes of the genera Aedes, Culex, and Anopheles, for transmission [4, 5]. Dirofilaria immitis harbors the obligate intracellular endosymbiont Wolbachia, which plays a critical role in worm development, fertility, and the host inflammatory response [1]. The molecular characterization of Wolbachia endosymbionts has revealed associations with canine dirofilariasis in endemic regions such as Sri Lanka [1]. Population genomics studies indicate an ancient origin of heartworms in canids, suggesting a long coevolutionary history between the parasite and its definitive hosts [6].
Fleas, primarily Ctenocephalides felis and Ctenocephalides canis, are ectoparasites that serve as vectors for several pathogens, including Dipylidium caninum and Bartonella species [7]. Integrated parasite control strategies must address both endoparasites and ectoparasites due to their overlapping transmission dynamics and the availability of combination preventive products [8, 9].
Transmission and Epidemiology
Transmission of D. immitis occurs when a mosquito ingests microfilariae during a blood meal from an infected dog [4, 10]. The microfilariae develop through L1 to L3 larval stages within the mosquito over a period of 10 to 14 days, depending on ambient temperature and humidity [11]. The infective L3 larvae are then deposited onto the skin of a new host during subsequent feeding and actively penetrate the bite wound [3]. Development to the adult stage occurs over approximately 6 to 7 months, with adult worms reaching the pulmonary arteries 70 to 120 days post infection [12].
Epidemiological studies have demonstrated the widespread distribution of D. immitis across tropical, subtropical, and temperate regions [7, 13, 14]. In Sri Lanka, subclinical infections of Babesia and Dirofilaria in dogs presented to veterinary teaching hospitals provide evidence for a silent reservoir of infection [13]. Molecular screening of mosquitoes in Slovenia has identified filarioid helminths, highlighting the importance of entomological surveillance for predicting transmission risk [4]. In the humid coastal zones of Brazil, epidemiological predictors and molecular characterization have confirmed the emergence of D. immitis in these environments [11]. Seroprevalence studies in rural areas of northern Peru have detected zoonotic vector-borne pathogens in domestic dogs, underscoring the public health implications of canine infections [14]. The first reported case of D. immitis in a coyote (Canis latrans) from Prince Edward Island demonstrates the expansion of the parasite into novel geographic regions and wildlife reservoirs [2]. Global research trends indicate a climate-driven expansion of Dirofilaria repens, a related species that also infects dogs and can cause zoonotic infections [15].
Flea infestations are similarly influenced by environmental conditions, with warm and humid climates supporting year-round populations [7]. The co-occurrence of heartworm and flea infestations in endemic regions necessitates integrated control approaches that target both parasites simultaneously [8, 9].
Clinical Signs and Pathophysiology
The clinical manifestations of canine heartworm disease are directly related to the number of adult worms, the duration of infection, and the host immune response [12, 16]. Clinicopathologic variables correlate with disease severity, including increased serum haptoglobin concentrations in microfilaremic dogs compared to amicrofilaremic dogs [16]. Dogs with low worm burdens (fewer than 25 worms) may remain asymptomatic for months to years [12]. Moderate to heavy infections (25 to 100 worms) typically present with cough, exercise intolerance, dyspnea, and weight loss [12, 17]. Severe infections (more than 100 worms) can lead to caval syndrome, characterized by right-sided heart failure, hemoglobinuria, and sudden death [17]. Gastric dilatation and volvulus has been reported in a dog with situs inversus and concurrent heartworm disease, although this association is likely coincidental [17].
Dirofilaria repens, a related species that localizes in subcutaneous tissues, can cause nodular dermatitis, pruritus, and in some cases, renal pathology [18, 19]. Clinico-pathological and renal morphological findings in dogs naturally infected with D. repens include glomerulonephritis and interstitial nephritis [18]. Co-infections with D. immitis and D. repens have been documented, including unusual localization of adult D. repens in an abdominal hernia sac [20].
Flea infestations cause direct dermatological effects, including flea allergy dermatitis (FAD), which results from hypersensitivity to flea salivary antigens [7]. Chronic FAD leads to alopecia, erythema, papules, and secondary pyoderma [7]. Fleas also serve as intermediate hosts for Dipylidium caninum, a cestode that causes intestinal parasitism in dogs [7].
Diagnosis
Diagnosis of canine heartworm disease relies on a combination of antigen testing, microfilarial detection, and imaging modalities [3, 21, 22]. Commercial ELISA kits detect circulating adult female D. immitis antigen, with high sensitivity and specificity in clinically suspected dogs [22]. Point-of-care tests, including the Pluslife Mini Dock system, have been developed for the simultaneous detection of D. immitis and D. repens and show comparative performance to the modified Knott's test [21]. Bayesian latent class modeling has been used to evaluate the relative accuracy of point-of-care tests for ruling in heartworm infection in clinically suspected dogs [22].
Microfilarial detection is performed using the modified Knott's test or direct blood smear examination [21, 23]. Seasonal studies of blood parasites in guard dogs have demonstrated the utility of these methods for detecting D. immitis and Dipetalonema reconditum [23]. Molecular diagnostic methods, including loop-mediated isothermal amplification (LAMP) targeting the cytochrome c oxidase subunit I (COI) gene, provide high sensitivity and specificity for epidemiological studies [24]. Quadruplex droplet digital PCR (ddPCR) assays have been developed for the rapid detection of molecular markers associated with macrocyclic lactone (ML) resistance and susceptibility in D. immitis [25]. Serological and molecular detection methods have been applied to pet dog populations in Pakistan, confirming the presence of D. immitis in this region [26].
Imaging techniques, including thoracic radiography and echocardiography, are used to assess the severity of pulmonary vascular disease and to visualize adult worms in the pulmonary arteries and right heart chambers [3, 17]. Ultrasonography is particularly useful for detecting worm mobility and assessing the response to adulticide therapy [19].
Diagnosis of flea infestations is based on visual inspection and the use of flea combs to recover adult fleas and flea feces (flea dirt) from the haircoat [7]. Enzyme-linked immunosorbent assays for flea salivary antigen can confirm exposure in cases of FAD [7].
Treatment
Treatment of canine heartworm disease involves adulticide therapy, microfilarial clearance, and supportive care [27, 28]. Traditional adulticide protocols utilize melarsomine dihydrochloride, an arsenical compound administered via deep intramuscular injection [28]. However, non-arsenical adulticide protocols using moxidectin and doxycycline have been systematically reviewed and meta-analyzed, demonstrating efficacy for the treatment of adult heartworm infection in dogs [27]. The combination of doxycycline, which targets Wolbachia endosymbionts, and moxidectin, a macrocyclic lactone, results in gradual adult worm death and reduced thromboembolic complications [27, 29]. A rare case of blood bronchial mucus with D. immitis adult worms after treatment with doxycycline and moxidectin has been reported, highlighting the potential for unusual clinical presentations during therapy [29].
Current issues in heartworm chemotherapy include the emergence of ML-resistant D. immitis isolates and the need for alternative treatment protocols [28]. The isolation and characterization of a novel glutamate-gated chloride channel subunit (GLC-2) from D. immitis provides insight into the molecular targets of MLs and potential mechanisms of resistance [30]. Comparative efficacy studies have demonstrated that six monthly doses of combination products containing sarolaner, moxidectin, and pyrantel are effective against ML-resistant D. immitis isolates [8].
Supportive care for dogs with heartworm disease includes exercise restriction, anti-inflammatory doses of corticosteroids, and management of concurrent conditions [12, 17]. Dogs with caval syndrome require surgical removal of adult worms via jugular venotomy [17].
Treatment of flea infestations involves the use of adulticides, insect growth regulators (IGRs), and environmental management [7]. Oral and topical formulations of isoxazolines (e.g., lotilaner, afoxolaner, sarolaner) provide rapid and sustained flea kill [8, 9]. IGRs such as lufenuron and methoprene inhibit flea egg and larval development, breaking the flea life cycle [7].
Prevention
Prevention of canine heartworm disease relies on the administration of macrocyclic lactones, including ivermectin, moxidectin, and selamectin, at monthly intervals [31, 9]. Sustained-release formulations of ivermectin have demonstrated efficacy and safety in preventing heartworm infection in dogs in endemic areas of Italy [31]. Novel chewable tablets containing lotilaner, moxidectin, praziquantel, and pyrantel provide broad-spectrum protection against heartworm disease, fleas, ticks, and intestinal parasites [9]. The concept of the dog heartworm and flea pill refers to oral combination products that deliver both an endectocide (for heartworm prevention) and an ectoparasiticide (for flea and tick control) in a single monthly dose [8, 9]. These products simplify compliance for pet owners and ensure consistent protection against multiple parasite species [8].
Integrated parasite control programs must consider the geographic and seasonal variation in mosquito and flea populations [11, 10]. Year-round administration of preventive medications is recommended in endemic regions, as even brief lapses in prophylaxis can result in infection [31, 9]. Mosquito surveillance using zoos as sentinel sites has been employed for operational detection of D. immitis in central Utah [10]. The development of D. immitis adult worms in NSG mice and the detection of parasite-derived microRNA provide new tools for studying parasite biology and evaluating preventive strategies [32].
Flea prevention is achieved through the consistent use of adulticides and IGRs, combined with environmental control measures such as vacuuming and washing pet bedding [7]. The integration of heartworm and flea prevention into a single monthly product reduces the number of treatments required and improves owner adherence [8, 9].
Macrocyclic Lactone Resistance
The emergence of ML-resistant D. immitis isolates poses a significant challenge to heartworm prevention programs [8, 28, 25]. Resistance is associated with mutations in the P-glycoprotein genes and alterations in glutamate-gated chloride channel subunits [30, 25]. Quadruplex ddPCR assays enable the rapid detection of molecular markers associated with ML resistance, facilitating surveillance and informed product selection [25]. Comparative efficacy studies have shown that combination products containing moxidectin remain effective against some ML-resistant isolates, although ongoing monitoring is essential [8]. The development of novel anthelmintic classes and alternative treatment protocols is a priority for managing resistance [28].
Integrated Parasite Control Strategies
Integrated parasite control (IPC) combines chemical, biological, and management interventions to reduce parasite burdens and minimize the risk of resistance [7, 8]. For canine heartworm disease and flea prevention, IPC includes the following components:
- Year-round administration of combination preventive products (dog heartworm and flea pill) containing an ML and an isoxazoline or other ectoparasiticide [8, 9].
- Environmental management to reduce mosquito and flea breeding sites, including removal of standing water and regular cleaning of indoor environments [7, 10].
- Vector surveillance and control using insecticide-treated screens or barriers in kennel settings [4, 10].
- Regular diagnostic testing for heartworm infection and flea infestations, including antigen testing and microfilarial examination [21, 22].
- Client education regarding the importance of compliance with preventive protocols and the risks of lapses in prophylaxis [31, 9].
The following Mermaid diagram illustrates the decision tree for integrated parasite control in dogs:
flowchart TD
A[Annual Wellness Examination], > B{Antigen Test Negative?}
B, >|Yes| C[Administer Monthly Dog Heartworm and Flea Pill]
B, >|No| D[Confirm with Microfilarial Test]
D, > E{Microfilariae Detected?}
E, >|Yes| F[Initiate Adulticide Protocol]
E, >|No| G[Repeat Antigen Test in 3 Months]
F, > H[Post-Treatment Antigen Test at 6 Months]
H, > I{Antigen Negative?}
I, >|Yes| C
I, >|No| J[Consider ML Resistance Testing]
J, > K[Adjust Preventive Product]
C, > L[Monthly Administration for 12 Months]
L, > M[Annual Re-testing]
Public Health and Zoonotic Considerations
Dirofilaria immitis and D. repens are zoonotic parasites, with humans serving as accidental hosts [15, 14]. Human infections typically present as pulmonary or subcutaneous nodules, which may be misdiagnosed as neoplasms [15, 19]. The climate-driven expansion of D. repens in Europe has increased the risk of human exposure [15]. Integrated parasite control in dogs reduces the zoonotic risk by decreasing the prevalence of microfilaremic animals in the environment [7, 14]. Flea-borne zoonoses, including Bartonella henselae and Dipylidium caninum, are also mitigated through effective flea control [7].
Conclusion
Canine heartworm disease and flea infestations represent significant veterinary and public health concerns that require integrated control strategies. The availability of combination products, including the dog heartworm and flea pill, simplifies prevention and improves compliance. Ongoing surveillance for ML resistance, advances in molecular diagnostics, and climate-driven changes in vector distribution necessitate continued research and adaptation of prevention protocols. The integration of chemical prevention, environmental management, and client education remains the cornerstone of effective parasite control in dogs.
References
[1] Loku Gamage N, Ranasinghe K, Rodrigo W. Molecular Characterization of Wolbachia Endosymbionts and Their Association With Canine Dirofilariasis in Colombo District, Sri Lanka. J Parasitol Res. 2026. https://pubmed.ncbi.nlm.nih.gov/42328691/
[2] Leaman LJ, Graham KF, Jones MEB, et al. First reported case of Dirofilaria immitis in a coyote (Canis latrans) from Prince Edward Island. Can Vet J. 2026. https://pubmed.ncbi.nlm.nih.gov/42266338/
[3] Nonnis F, Corda A, Zeinoun P, et al. Feline heartworm disease in endemic settings: an integrated diagnostic approach. Res Vet Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/42225012/
[4] Glinšek Biškup U, Knap N, Korva M, et al. Molecular screening of mosquitoes for filarioid helminths in Slovenia. Parasit Vectors. 2026. https://pubmed.ncbi.nlm.nih.gov/42083038/
[5] Amarasinghe S, Ranasinghe K, Rodrigo W, et al. First molecular characterization of Dirofilaria vector species and the distribution of canine dirofilariasis in Gampaha district, Sri Lanka. Front Cell Infect Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/42064220/
[6] Power RI, Abdullah S, Walden HS, et al. Population genomics reveals an ancient origin of heartworms in canids. Commun Biol. 2026. https://pubmed.ncbi.nlm.nih.gov/41559308/
[7] Khalife S, El Safadi D. Canine vector-borne diseases in Lebanon: Unveiling prevalence trends and risk factors for public health and disease control. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/42150803/
[8] Rodriguez J, Jones S, Mahabir S, et al. Comparative efficacy of six monthly doses of Simparica Trio (sarolaner, moxidectin, and pyrantel chewable tablets) versus NexGard Plus (afoxolaner, moxidectin, and pyrantel chewable tablets) against a macrocyclic lactone-resistant Dirofilaria immitis isolate in dogs. Parasit Vectors. 2026. https://pubmed.ncbi.nlm.nih.gov/42087216/
[9] Young L, Reinemeyer CR, Abdelmoneim M, et al. Efficacy of a novel chewable tablet (Credelio Quattro) containing lotilaner, moxidectin, praziquantel, and pyrantel for the prevention of heartworm disease (Dirofilaria immitis) in dogs. Parasit Vectors. 2026. https://pubmed.ncbi.nlm.nih.gov/41943128/
[10] Hammond NG, Todaro A, Fairbanks KA, et al. Mosquito (Diptera: Culicidae) surveillance for Dirofilaria immitis (Rhabditida: Onchocercidae) using a zoo as a focus for operational detection in central Utah. J Med Entomol. 2026. https://pubmed.ncbi.nlm.nih.gov/41723581/
[11] Monteiro ACMP, Ribeiro CM, Fehlberg HF, et al. Emergence of Dirofilaria immitis in humid coastal zones: Epidemiological predictors and molecular characterization. Vet J. 2026. https://pubmed.ncbi.nlm.nih.gov/41990946/
[12] Kim M, Seo M, Cho J, et al. Clinicopathologic variables according to disease severity in dogs with heartworm disease. BMC Vet Res. 2026. https://pubmed.ncbi.nlm.nih.gov/42152057/
[13] Ranahewa DK, Dangolla A, Rajakaruna RS, et al. Subclinical Infections of Babesia and Dirofilaria in Dogs Presented to a Veterinary Teaching Hospital: Evidence for a Silent Reservoir of Infection in Sri Lanka. Acta Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/42113286/
[14] Julca LA, Salas-Fajardo MY, Guevara S, et al. Seroprevalence of zoonotic vector-borne pathogens in domestic dogs from rural areas in northern Peru. Top Companion Anim Med. 2026. https://pubmed.ncbi.nlm.nih.gov/42035833/
[15] Aguilar-Elena R, Rodríguez-Escolar I, Collado-Cuadrado M, et al. Global Research Trends in Emerging Zoonosis Due to (the Filarial Nematode) Dirofilaria repens (1955-2025): A Bibliometric Analysis of a Climate-Driven Expansion. Pathogens. 2026. https://pubmed.ncbi.nlm.nih.gov/42075713/
[16] Chocobar MLE, Eckersall DP, Panarese R, et al. Comparison of Haptoglobin Concentrations Between Microfilaremic and Amicrofilaremic Dogs Infected by Dirofilaria immitis. Vet Clin Pathol. 2026. https://pubmed.ncbi.nlm.nih.gov/41612543/
[17] Stokowski S, Steuri SK, Lux C, et al. Gastric Dilatation and Volvulus and Heartworm Disease in a Dog With Situs Inversus. Vet Radiol Ultrasound. 2026. https://pubmed.ncbi.nlm.nih.gov/42011803/
[18] Szabó KÉ, Aresu L, Müller L, et al. Clinico-pathological and renal morphological findings in dogs naturally infected with Dirofilaria repens. BMC Vet Res. 2026. https://pubmed.ncbi.nlm.nih.gov/42069630/
[19] Malghem J, Vande Berg B, Lengelé B, et al. Dirofilaria repens Parasite: Review with Emphasis on Ultrasound Findings with Looking for Worm Mobility. J Belg Soc Radiol. 2026. https://pubmed.ncbi.nlm.nih.gov/41909165/
[20] Rajković M, Rajković V, Bogunović D. Dirofilaria immitis and Dirofilaria repens co-infection in a microfilaremic dog from Negotin, Eastern Serbia: Unusual localization of adult Dirofilaia repens in an abdominal hernia sac. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/41741045/
[21] Sanders TL, Starnes A, Kelly MA, et al. Comparative performance of the novel, point-of-care Pluslife Mini Dock Dirofilaria immitis/Dirofilaria repens detection test with the modified Knott's test in dogs. Parasit Vectors. 2026. https://pubmed.ncbi.nlm.nih.gov/42104384/
[22] Atkinson PJ, Quimby C, Datt A, et al. Relative accuracy of point-of-care tests to rule-in heartworm infection in clinically suspected dogs using Bayesian latent class modelling. Prev Vet Med. 2026. https://pubmed.ncbi.nlm.nih.gov/41520422/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.
[23] Roya GM, Yagoob G, Bahram AT. Seasonal study of Blood Parasites: Dirofilaria Immitis and Dipetalonema Reconditum in the Guard Dogs of Tabriz city, Iran. Arch Razi Inst. 2025. https://pubmed.ncbi.nlm.nih.gov/41769291/
[24] Genc MG, Erol U, Sahın OF, et al. Application of COI-LAMP for Detection of Dirofilaria immitis with High Sensitivity and Specificity in Epidemiological Studies. Acta Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/41801609/
[25] Kumar S, Lalicon IK, Prichard RK, et al. Development and evaluation of quadruplex droplet digital PCR assay for rapid detection of molecular markers associated with macrocyclic lactone resistance and susceptibility in Dirofilaria immitis. Int J Parasitol Drugs Drug Resist. 2026. https://pubmed.ncbi.nlm.nih.gov/41558254/
[26] Safdar I, Ur Rehman S, Roman U, et al. Serological and molecular detection of Dirofilaria immitis in pet dogs of Lahore, Pakistan. Ann Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/41881496/
[27] Santiwattanatarm T, Sakcamduang W, Kongkaew C, et al. A systematic review and meta-analysis of non-arsenical adulticide protocols using moxidectin and doxycycline for the treatment of adult heartworm infection in dogs. Curr Res Parasitol Vector Borne Dis. 2026. https://pubmed.ncbi.nlm.nih.gov/42007372/
[28] Geary TG. Current issues in heartworm chemotherapy. Parasit Vectors. 2026. https://pubmed.ncbi.nlm.nih.gov/41851772/
[29] Nogueira LLDC, Araújo BVS, Antunes JMAP, et al. Blood bronchial mucus with Dirofilaria immitis adult worms after the treatment with doxycycline and moxidectin: a rare case presentation. Parasitology. 2026. https://pubmed.ncbi.nlm.nih.gov/41549761/
[30] Nichols J, Forrester SG. Isolation and characterization of a novel glutamate-gated chloride channel subunit (GLC-2) from the canine heartworm Dirofilaria immitis. Mol Biochem Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/41581768/
[31] Genchi M, Venco L, Fozzer M, et al. Efficacy and safety of a sustained-release formulation of ivermectin (FILAPREV) in preventing heartworm infection (Dirofilaria immitis) in dogs in two endemic areas of Italy. Parasit Vectors. 2026. https://pubmed.ncbi.nlm.nih.gov/42087229/
[32] Nakhale M, Hess JA, Oliver E, et al. Development of Dirofilaria immitis adult worms in NSG mice, detection of parasite-derived microRNA and comparative analysis of laboratory isolates. Sci Rep. 2026. https://pubmed.ncbi.nlm.nih.gov/41617897/
[33] Zanfagnini LG, Chocobar MLE, Schmidt EMS, et al. Unveiling filariid infections in dogs living in the Western Amazon, Brazil. Comp Immunol Microbiol Infect Dis. 2026. https://pubmed.ncbi.nlm.nih.gov/41818949/
[34] Boontuboon W, Sakcamduang W, Osathanon R, et al. Evaluation of platelet surface-associated immunoglobulin positivity and its association with hematologic findings and vector-borne pathogens in thrombocytopenic dogs. J Vet Intern Med. 2026. https://pubmed.ncbi.nlm.nih.gov/41789552/
[35] Martínez-Durán D, Mujika M, Morales M, et al. Vector-borne pathogens in Spanish greyhounds from Central Spain: Prevalence and hematobiochemical findings. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/41741046/